Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.
about
Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theBloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort StudiesEvaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric PatientsProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.An Italian consensus for invasive candidiasis management (ITALIC).What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.Non-cultural methods for the diagnosis of invasive fungal disease.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.Bloodstream infections in internal medicine.Persistent spontaneous fungal peritonitis secondary to Candida albicans in a patient with alcoholic cirrhosis and review of the literature.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.Value of platelet count in the early diagnosis of nosocomial invasive fungal infections in premature infants.Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.β-D-glucan testing is important for diagnosis of invasive fungal infections.Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysisUse of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study.
P2860
Q33603993-B51304E4-64F0-49A7-A02F-E2EB58EBC03AQ34212799-2669495B-5DD1-4B84-BB88-58AC15BE316EQ34260841-FE1F34F9-75C8-4BBA-B4BE-2961384ED992Q35683091-7B5BCF0C-5895-42E9-B05A-C6311BAE530CQ35968648-C733D3C1-BD1D-43B2-9453-536DA3CE20C4Q37089475-4AFD4518-D5E1-4593-8CC3-8F58EAFCFA31Q38150728-8F1C0BDB-007C-400E-A245-F3B368D05201Q38165883-6BEEBAE9-85A3-45F7-B769-8778F7B59CAAQ38203447-A272A238-E5ED-4A15-8E3E-373987FAE6C2Q38220697-3D938C64-0136-410E-B994-5F4EB60809A1Q38262058-123BC6FC-2B25-4394-8883-173C191CC136Q38266817-84AC8F9B-E060-428C-A7DE-36B0E2FC59B0Q38611989-98E4ABF5-A0CF-4D01-A20E-0A118C575618Q38694666-7AE8E157-F056-433E-A9B3-31521C649FD4Q39016489-7F23E046-745C-480B-82A8-9FDD61C9A908Q39367519-3854BF68-8265-4C16-AA2B-032C7EBC7BD4Q40101829-49F98CD1-84B6-4099-951D-547094BB2472Q40128716-58A8B210-26C0-4B29-A2C4-C189ADD09128Q40265724-97C2A1FE-C02E-48CE-A186-0DF1AA13EEC6Q40948260-4B02E61A-1609-4AA3-AAED-D9C089A406A0Q41128217-D993A583-AECF-486C-BBE7-BB9DAB0206CCQ41687058-BB9219DC-FF74-4FB1-8F70-22463A5E0BE7Q41740943-70EF8877-49B2-44A7-ACFD-C4D79DBF4C56Q41867984-3EBEB816-90F8-4C20-9292-258B07BA1493Q42559150-49AB3B61-7259-4BB9-AE1B-19DA4DF9DB0FQ50072321-7D32A51A-D3B4-4391-814A-350B0B3F5AEAQ55105395-0F683ED1-583B-4A4C-B47D-A1B4EBAFDC18
P2860
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical performance of the (1 ...... andida bloodstream infections.
@ast
Clinical performance of the (1 ...... andida bloodstream infections.
@en
type
label
Clinical performance of the (1 ...... andida bloodstream infections.
@ast
Clinical performance of the (1 ...... andida bloodstream infections.
@en
prefLabel
Clinical performance of the (1 ...... andida bloodstream infections.
@ast
Clinical performance of the (1 ...... andida bloodstream infections.
@en
P2093
P2860
P356
P1476
Clinical performance of the (1 ...... andida bloodstream infections.
@en
P2093
Alessandra Mularoni
Claudio Viscoli
Elena Nicco
Elisa Furfaro
Emanuele Delfino
Malgorzata Mikulska
Matteo Bassetti
Valerio Del Bono
P2860
P304
P356
10.1128/CVI.05408-11
P50
P577
2011-10-12T00:00:00Z